• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.5 Contact Hour(s)

    Release Date

    Sunday, July 14, 2019

    Offline Date

    Wednesday, July 14, 2021

    ACPE Expiration Date

    Wednesday, July 14, 2021

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $6.00

    • Overview

      According to the International Foundation for Functional Gastrointestinal Disorders irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder worldwide with an estimated prevalence rate of 10-15%.  While most patients do not recognize the symptoms as IBS it is the most common disorder seen and diagnosed by gastroenterologists.  In the United States between 2.4-3.5 million physician visits take place annually for symptoms related to IBS.  While IBS appears to be more common among females approximately 35-40% of males may experience symptoms related to IBS as well.  There are different types of IBS resulting in varying symptoms and treatments.  This knowledge-based activity will educate pharmacists on the diagnosis and management of IBS, as well as the importance of counseling patients to adhere to lifestyle modifications and their treatment.

      Handouts

      • Slide Document :   18264H01_6pp.pdf
      • Slide Document :   18264H01_2pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Recommend nonpharmacological measures to manage the symptoms of IBS when counseling patients
      Recognize the pathophysiology and symptomatology of IBS
      Define Irritable Bowel Syndrome (IBS) and its diagnostic criteria
      Determine the risk factors and comorbidities related to IBS
      Identify effective elements of an appropriate drug therapy evaluation for IBS

      Pharmacy Technician

      Identify effective elements of an appropriate drug therapy evaluation for IBS
      Recommend nonpharmacological measures to manage the symptoms of IBS when counseling patients
      Recognize the pathophysiology and symptomatology of IBS
      Determine the risk factors and comorbidities related to IBS
      Define Irritable Bowel Syndrome (IBS) and its diagnostic criteria

      Nurse

      Recommend nonpharmacological measures to manage the symptoms of IBS when counseling patients
      Define Irritable Bowel Syndrome (IBS) and its diagnostic criteria
      Identify effective elements of an appropriate drug therapy evaluation for IBS
      Determine the risk factors and comorbidities related to IBS
      Recognize the pathophysiology and symptomatology of IBS
    • Activity Type

      Knowledge

      CE Broker

      20-664757

      Universal Activity Number

      Pharmacist 0798-0000-18-264-H01-P
      Pharmacy Technician 0798-0000-18-264-H01-T
      Nurse 0798-0000-18-264-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Brooke  Fidler, PharmD
      Associate Professor, LIU Pharmacy, Arnold & Marie Schwartz College of Pharmacy and Health Sciences

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).